Vascular factors in dementia: An overview

Journal of the Neurological Sciences

Volumn 226, Issue 1-2 SPEC.ISS., 2004, Pages 19-23

  DeCarli, Charles ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer disease; Cerebrovascular disease; Dementia

Indexed keywords

ALZHEIMER DISEASE; BRAIN FUNCTION; CEREBROVASCULAR DISEASE; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; DEMENTIA; DIAGNOSTIC PROCEDURE; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; ALZHEIMER DISEASE; BRAIN; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; DEMENTIA, VASCULAR; DISEASE PROGRESSION; HUMANS;

EID: 8744300045     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2004.09.005     Document Type: Conference Paper

References (90)

1. L.E. Hebert, L.A. Beckett, P.A. Scherr, and D.A. Evans Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050 Alzheimer Dis. Assoc. Disord. 15 4 2001 169 173
2. D.A. Evans, H.H. Funkenstein, M.S. Albert, P.A. Scherr, N.R. Cook, and M.J. Chown Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported JAMA 262 18 1989 2551 2556
3. R.B. Sayetta Rates of senile dementia, Alzheimer's type, in the Baltimore longitudinal study J. Chronic. Dis. 39 4 1986 271 286
4. P.A. Wolf, R.B. D'Agostino, A.J. Belanger, and W.B. Kannel Probability of stroke: a risk profile from the Framingham study Stroke 22 3 1991 312 318
5. D. Mungas, B. Reed, W.G. Ellis, and W.J. Jagust The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease Arch. Neurol. 58 2001 1243 1247
6. H. Chui Dementia due to subcortical ischemic vascular disease Clin. Cornerstone 3 4 2001 40 51
7. H.C. Chui, W. Mack, J.E. Jackson, D. Mungas, B.R. Reed, and J. Tinklenberg Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability Arch. Neurol. 57 2 2000 191 196
8. H. Chui Vascular dementia, a new beginning: shifting focus from clinical phenotype to ischemic brain injury Neurol. Clin. 18 4 2000 951 978
9. C.C. Wu, D. Mungas, C.I. Petkov, J.L. Eberling, P.A. Zrelak, and M.H. Buonocore Brain structure and cognition in a community sample of elderly Latinos Neurology 59 3 2002 383 391
10. A.J. Slooter, C.M. van Duijn, M.L. Bots, A. Ott, M.B. Breteler, and J. De Voecht Apolipoprotein E genotype, atherosclerosis, and cognitive decline: the Rotterdam Study J. Neural Transm. Suppl. 53 1998 17 29
11. L.J. Launer, G.W. Ross, H. Petrovitch, K. Masaki, D. Foley, and L.R. White Midlife blood pressure and dementia: the Honolulu-Asia aging study Neurobiol. Aging 21 1 2000 49 55
12. I. Skoog, B. Lernfelt, S. Landahl, B. Palmertz, L.A. Andreasson, and L. Nilsson 15-year longitudinal study of blood pressure and dementia Lancet 347 9009 1996 1141 1145
13. M. Kivipelto, E.L. Helkala, T. Hanninen, M.P. Laakso, M. Hallikainen, and K. Alhainen Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study Neurology 56 12 2001 1683 1689
14. M. Kivipelto, E.L. Helkala, M.P. Laakso, T. Hanninen, M. Hallikainen, and K. Alhainen Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study BMJ 322 7300 2001 1447 1451
15. M. Kivipelto, M.P. Laakso, J. Toumilehto, A. Nissinen, and H. Soininen Hypertension and hypercholesterolaemia as risk factors for Alzheimer's disease: potential for pharmacological intervention CNS Drugs 16 7 2002 435 444
16. S.E. Vermeer, N.D. Prins, T. den Heijer, A. Hofman, P.J. Koudstaal, and M.M. Breteler Silent brain infarcts and the risk of dementia and cognitive decline N. Engl. J. Med. 348 13 2003 1215 1222
17. S. Seshadri, A. Beiser, J. Selhub, P.F. Jacques, I.H. Rosenberg, and R.B. D'Agostino Plasma homocysteine as a risk factor for dementia and Alzheimer's disease N. Engl. J. Med. 346 7 2002 476 483
18. M.A. Weber Role of hypertension in coronary artery disease Am. J. Nephrol. 16 3 1996 210 216
19. R.F. Gillum Coronary heart disease, stroke, and hypertension in a U.S. national cohort: the NHANES I Epidemiologic follow-up study. National health and nutrition examination survey Ann. Epidemiol. 6 4 1996 259 262
20. Z.J. Zheng, A.R. Sharrett, L.E. Chambless, W.D. Rosamond, F.J. Nieto, and D.S. Sheps Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk In Communities (ARIC) study Atherosclerosis 131 1 1997 115 125
21. V. Papademetriou, P. Narayan, H. Rubins, D. Collins, and S. Robins Influence of risk factors on peripheral and cerebrovascular disease in men with coronary artery disease, low high-density lipoprotein cholesterol levels, and desirable low-density lipoprotein cholesterol levels. HIT Investigators. Department of Veterans Affairs HDL Intervention Trial Am. Heart J. 136 4 Pt 1 1998 734 740
22. R. Cooper, J. Cutler, P. Desvigne-Nickens, S.P. Fortmann, L. Friedman, and R. Havlik Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention Circulation 102 25 2000 3137 3147
23. R. Antikainen, P. Jousilahti, and J. Tuomilehto Systolic blood pressure, isolated systolic hypertension and risk of coronary heart disease, strokes, cardiovascular disease and all-cause mortality in the middle-aged population J. Hypertens. 16 5 1998 577 583
24. A. Boon, J. Lodder, L. Heuts-van Raak, and F. Kessels Silent brain infarcts in 755 consecutive patients with a first-ever supratentorial ischemic stroke. Relationship with index-stroke subtype, vascular risk factors, and mortality Stroke 25 12 1994 2384 2390
25. T. Brott, T. Tomsick, W. Feinberg, C. Johnson, J. Biller, and J. Broderick Baseline silent cerebral infarction in the asymptomatic carotid atherosclerosis study Stroke 25 6 1994 1122 1129
26. M.D. Ezekowitz, K.E. James, S.M. Nazarian, J. Davenport, J.P. Broderick, and S.R. Gupta Silent cerebral infarction in patients with nonrheumatic atrial fibrillation. The Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Circulation 92 8 1995 2178 2182
27. H.S. Jørgensen, H. Nakayama, H.O. Raaschou, J. Gam, and T.S. Olsen Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: the Copenhagen stroke study [see comments] Stroke 25 1 1994 97 104
28. C.S. Kase, P.A. Wolf, E.H. Chodosh, H.B. Zacker, M. Kelly-Hayes, and W.B. Kannel Prevalence of silent stroke in patients presenting with initial stroke: the Framingham study Stroke 20 7 1989 850 852
29. A. Shinkawa, K. Ueda, Y. Kiyohara, I. Kato, K. Sueishi, and M. Tsuneyoshi Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study Stroke 26 3 1995 380 385
30. A. Steingart, K. Lau, A. Fox, F. Diaz, M. Fisman, and V. Hachinski The significance of white matter lucencies on CT scan in relation to cognitive impairment Can. J. Neurol. Sci. 13 4 Suppl. 1986 383 384
31. V.C. Hachinski, P. Potter, and H. Merskey Leuko-araiosis: an ancient term for a new problem Can. J. Neurol. Sci. 13 4 Suppl. 1986 533 534
32. V.C. Hachinski, P. Potter, and H. Merskey Leuko-araiosis Arch. Neurol. 44 1 1987 21 23
33. A. Steingart, V.C. Hachinski, C. Lau, A.J. Fox, F. Diaz, and R. Cape Cognitive and neurologic findings in subjects with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis) Arch. Neurol. 44 1 1987 32 35
34. A. Steingart, V.C. Hachinski, C. Lau, A.J. Fox, H. Fox, and D. Lee Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis) Arch. Neurol. 44 1 1987 36 39
35. N.C. Yue, A.M. Arnold, W.T. Longstreth Jr., A.D. Elster, C.A. Jungreis, and D.H. O'Leary Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study [see comments] Radiology 202 1 1997 33 39
36. A. Ott, R.P. Stolk, F. van Harskamp, H.A. Pols, A. Hofman, and M.M. Breteler Diabetes mellitus and the risk of dementia: the Rotterdam study [see comments] Neurology 53 9 1999 1937 1942
37. T.A. Manolio, R.A. Kronmal, and G.l. Burke Magnetic resonance abnormalities and cardiovascular disease in older adults: the cardiovascular health study Stroke 25 1994 318 327
38. D. Liao, L. Cooper, J. Cai, J.F. Toole, N.R. Bryan, and R.G. Hutchinson Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC study. Atherosclerosis risk in communities study Stroke 27 12 1996 2262 2270
39. D. Liao, L. Cooper, J. Cai, J. Toole, N. Bryan, and G. Burke The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study Neuroepidemiology 16 3 1997 149 162
40. G.E. Swan, C. DeCarli, B.L. Miller, T. Reed, P.A. Wolf, and L.M. Jack Association of midlife blood pressure to late-life cognitive decline and brain morphology Neurology 51 4 1998 986 993
41. C. DeCarli, B.L. Miller, G.E. Swan, T. Reed, P.A. Wolf, and J. Garner Predictors of brain morphology for the men of the NHLBI twin study Stroke 30 3 1999 529 536
42. S. Miyao, A. Takano, J. Teramoto, and A. Takahashi Leukoaraiosis in relation to prognosis for patients with lacunar infarction Stroke 23 10 1992 1434 1438
43. J.Y. Streifler, M. Eliasziw, and A.J. Fox Prognostic importance of leukoaraiosis in patients with ischemic events and carotid artery disease Stroke 30 1999 254
44. T.A. Manolio, G.L. Burke, D.H. O'Leary, G. Evans, N. Beauchamp, and L. Knepper Relationships of cerebral MRI findings to ultrasonographic carotid atherosclerosis in older adults: the cardiovascular health study. CHS collaborative research group Arterioscler. Thromb. Vasc. Biol. 19 2 1999 356 365
45. F.E. de Leeuw, J. Cees De Groot, M. Oudkerk, J.C. Witteman, A. Hofman, and J. van Gijn Aortic atherosclerosis at middle age predicts cerebral white matter lesions in the elderly Stroke 31 2 2000 425 429
46. J.A. Salerno, D.G. Murphy, B. Horwitz, C. DeCarli, J.V. Haxby, and S.I. Rapoport Brain atrophy in hypertension. A volumetric magnetic resonance imaging study Hypertension 20 3 1992 340 348
47. T.L. Strassburger, H.C. Lee, E.M. Daly, J. Szczepanik, J.S. Krasuski, and M.J. Mentis Interactive effects of age and hypertension on volumes of brain structures Stroke 28 7 1997 1410 1417
48. G.E. Swan, C. DeCarli, B.L. Miller, T. Reed, P.A. Wolf, and D. Carmelli Biobehavioral characteristics of nondemented older adults with subclinical brain atrophy Neurology 54 11 2000 2108 2114
49. G. Gesztelyi, W. Finnegan, J.A. DeMaro, J.Y. Wang, J.L. Chen, and J. Fenstermacher Parenchymal microvascular systems and cerebral atrophy in spontaneously hypertensive rats Brain Res. 611 2 1993 249 257
50. A. Tajima, F.J. Hans, D. Livingstone, L. Wei, W. Finnegan, and J. DeMaro Smaller local brain volumes and cerebral atrophy in spontaneously hypertensive rats Hypertension 21 1 1993 105 111
51. M.J. Mentis, J. Salerno, B. Horwitz, C. Grady, M.B. Schapiro, and D.G. Murphy Reduction of functional neuronal connectivity in long-term treated hypertension Stroke 25 3 1994 601 607
52. J.L. Price, and J.C. Morris Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease Ann. Neurol. 45 3 1999 358 368
53. J.C. Morris, and A.L. Price Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease J. Mol. Neurosci. 17 2 2001 101 118
54. S. Seshadri, P.A. Wolf, A. Beiser, M.F. Elias, R. Au, and C.S. Kase Stroke risk profile predicts brain volume and cognitive function in stroke-free subjects: the Framingham study Stroke 32 1 2001 321-c
55. R.B. D'Agostino, P.A. Wolf, A.J. Belanger, and W.B. Kannel Stroke risk profile: adjustment for antihypertensive medication. The Framingham study Stroke 25 1 1994 40 43
56. D. Knopman, L.L. Boland, T. Mosley, G. Howard, D. Liao, and M. Szklo Cardiovascular risk factors and cognitive decline in middle-aged adults Neurology 56 1 2001 42 48
57. M.C. Morris, P.A. Scherr, L.E. Hebert, D.A. Bennett, R.S. Wilson, and R.J. Glynn Association between blood pressure and cognitive function in a biracial community population of older persons Neuroepidemiology 21 3 2002 123 130
58. D.A. Snowdon, L.H. Greiner, J.A. Mortimer, K.P. Riley, P.A. Greiner, and W.R. Markesbery Brain infarction and the clinical expression of Alzheimer disease. The Nun study JAMA 277 1997 813 817
59. A. Heyman, G.G. Fillenbaum, and K.A. Welsh-Bohmer Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to establish a registry for Alzheimer's disease Neurology 51 1998 159 162
60. M.M. Esiri, G.K. Wilcock, and J.H. Morris Neuropathological assessment of the lesions of significance in vascular dementia J. Neurol. Neurosurg. Psychiatry 63 6 1997 749 753
61. Z. Nagy, M.M. Esiri, K.A. Jobst, J.H. Morris, E.M. King, and B. McDonald The effects of additional pathology on the cognitive deficit in Alzheimer disease J. Neuropathol. Exp. Neurol. 56 2 1997 165 170
62. J.A. Schneider, R.S. Wilson, E.J. Cochran, J.L. Bienias, S.E. Arnold, and D.A. Evans Relation of cerebral infarctions to dementia and cognitive function in older persons Neurology 60 7 2003 1082 1088
63. J.H. Lee, J.M. Olichney, L.A. Hansen, C.R. Hofstetter, and L.J. Thal Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease Arch. Neurol. 57 10 2000 1474 1479
64. J.M. Lafosse, B.R. Reed, D. Mungas, S.B. Sterling, H. Wahbeh, and W.J. Jagust Fluency and memory differences between ischemic vascular dementia and Alzheimer's disease Neuropsychology 11 4 1997 514 522
65. N. Wolfe, R. Linn, V.L. Babikian, J.E. Knoefel, and M.L. Albert Frontal systems impairment following multiple lacunar infarcts Arch. Neurol. 47 2 1990 129 132
66. J.L. Cummings, B. Miller, M.A. Hill, and R. Neshkes Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type Arch. Neurol. 44 4 1987 389 393
67. T.K. Tatemichi, D.W. Desmond, and I. Prohovnik Strategic infarcts in vascular dementia. a clinical and brain imaging experience Arzneimittel- Forschung 45 3A 1995 371 385
68. T.K. Tatemichi, D.W. Desmond, I. Prohovnik, D.T. Cross, T.I. Gropen, and J.P. Mohr Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? Neurology 42 10 1992 1966 1979
69. B.R. Reed, J.L. Eberling, D. Mungas, M.W. Weiner, and W.J. Jagust Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease Ann. Neurol. 48 3 2000 275 284
70. M.F. Elias, P.A Wolf, R.B. D'Agostino, J. Cobb, and L.R. White Untreated blood pressure level is inversely related to cognitive functioning: the Framingham study Am. J. Epidemiol. 138 1993 353 364
71. P.K. Elias, R.B. D'Agostino, M.F. Elias, and P.A. Wolf Blood pressure, hypertension, and age as risk factors for poor cognitive performance Exp. Aging Res. 21 4 1995 393 417
72. P.K. Elias, M.F. Elias, R.B. D'Agostino, L.A. Cupples, P.W. Wilson, and H. Silbershatz NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham study Diabetes Care 20 9 1997 1388 1395
73. M.F. Elias, M.A. Robbins, P.K. Elias, and D.H. Streeten A longitudinal study of blood pressure in relation to performance on the Wechsler adult intelligence scale Health Psychol. 17 6 1998 486 493
74. M.F. Elias Effects of chronic hypertension on cognitive functioning Geriatrics 53 Suppl 1(6) 1998 S49 S52
75. L.J. Launer, K. Masaki, H. Petrovich, D. Foley, and R.J. Havlik The association between mid-life blood pressure levels and late-life cognitive function. The Honolulu-Asia aging study JAMA 274 1995 1846 1851
76. G.E. Swan, D. Carmelli, and A. LaRue Relationship between blood pressure during middle age and cognitive impairment in old age: the Western Collaborative group study Aging Neuropsychol. Cognition 3 1996 241 250
77. A.J. Slooter, M. Cruts, S. Kalmijn, A. Hofman, M.M. Breteler, and C. Van Broeckhoven Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam study Arch. Neurol. 55 7 1998 964 988
78. C. DeCarli, T. Reed, B.L. Miller, P.A. Wolf, G.E. Swan, and D. Carmelli Impact of apolipoprotein E epsilon4 and vascular disease on brain morphology in men from the NHLBI twin study Stroke 30 8 1999 1548 1553
79. D.T. Laskowitz, H. Sheng, R.D. Bart, K.A. Joyner, A.D. Roses, and D.S. Warner Apolipoprotein E-deficient mice have increased susceptibility to focal cerebral ischemia J. Cereb. Blood Flow Metab. 17 7 1997 753 758
80. O. Ukkola, K. Kervinen, P.I. Salmela, K. von Dickhoff, M. Laakso, and Y.A. Kesaniemi Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus Atherosclerosis 101 1 1993 9 15
81. A. Ott, A.J. Slooter, A. Hofman, F. van Harskamp, J.C. Witteman, and C. Van Broeckhoven Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam study Lancet 351 9119 1998 1840 1843
82. C. Dufouil, C. Tzourio, C. Brayne, C. Berr, P. Amouyel, and A. Alperovitch Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers Epidemiology 11 3 2000 280 284
83. D. Carmelli, G.E. Swan, T. Reed, G.D. Schellenberg, and J.C. Christian The effect of apolipoprotein E epsilon4 in the relationships of smoking and drinking to cognitive function Neuroepidemiology 18 3 1999 125 133
84. D. Carmelli, G.E. Swan, T. Reed, B. Miller, P.A. Wolf, and G.P. Jarvik Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins Neurology 50 6 1998 1580 1585
85. M.N. Haan, L. Shemanski, W.J. Jagust, T.A. Manolio, and L. Kuller The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons JAMA 282 1 1999 40 46
86. A. Hofman, A. Ott, M.M. Breteler, M.L. Bots, A.J. Slooter, and F. van Harskamp Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [see comments] Lancet 349 9046 1997 151 154
87. D.L. Sparks, S.W. Scheff, H. Liu, T.M. Landers, C.M. Coyne, and J.C. Hunsaker III Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension J. Neurol. Sci. 131 2 1995 162 169
88. D.L. Sparks Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann. N.Y. Acad. Sci. 826 1997 128 146
89. D.L. Sparks, T.A. Martin, D.R. Gross, and J.C. Hunsaker III Link between heart disease, cholesterol, and Alzheimer's disease: a review Microsc. Res. Tech. 50 4 2000 287 290
90. H. Petrovitch, L.R. White, G. Izmirilian, G.W. Ross, R.J. Havlik, and W. Markesbery Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging study Neurobiol. Aging 21 1 2000 57 62